Authors: GINSBURG AD LEVINE MN BOWMAN DM OLIVOTTO IA FIELDS LA LITTLE CD CANTIN J MCGREGOR M GOLDHIRSCH A BRAMWELL V GELMON K BRYCE C ALLAN S NORRIS B LATREILLE J PATERSON ADH TOMIAK E TREMBLAY G BAIRD R BECKER P BUTTS C DANCEY JT GOEL R KVERN B MILNE C NAROD S NOLAN E THURLOW WH WONG R

Citation: Ad. Ginsburg et al., ADJUVANT SYSTEMIC THERAPY FOR WOMEN WITH NODE-NEGATIVE BREAST-CANCER, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 43-51

Authors: BUTTS C ZUBKOFF I ROBBINS DS CAO S SARZOTTI M

Citation: C. Butts et al., DNA IMMUNIZATION OF INFANTS - POTENTIAL AND LIMITATIONS, Vaccine, 16(14-15), 1998, pp. 1444-1449

Authors: OSOBA D RUSTHOVEN J BUTTS C YELLE L GRENVILLE A FINDLAY H

Citation: D. Osoba et al., VALIDITY OF THE QLQ-M28 AND QLQ-V28 NAUSEA AND VOMITING FORMS OF THE EORTC QLQ-C30, Quality of life research, 6(5), 1997, pp. 7-7

Authors: RUSTHOVEN J EISENHAUER E BUTTS C GREGG R DANCEY J FISHER B IGLESIAS J

Citation: J. Rusthoven et al., PHASE-II TRIAL OF THE MULTITARGETED ANTIFOLATE LY231514 (MTA) AS FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC), European journal of cancer, 33, 1997, pp. 1045-1045

Authors: BUTTS C DROUIN J TAYLOR R MCLEISH W

Citation: C. Butts et al., HODGKINS-DISEASE IN CLL, American journal of hematology, 48(2), 1995, pp. 134-135

Authors: HUEBSCH L LEGER C BREDESON C BURNELL M BUTTS C GENEST P GIULIVI A MARKMAN S MCDIARMID S VANDERJAGT R

Citation: L. Huebsch et al., HIGH-DOSE CHEMORADIOTHERAPY WITH UNPURGED MARROW (BM) AND OR BLOOD STEM-CELL (BC) SUPPORT FOR FOLLICULAR NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000208-10000208